Concepedia
Statistics
Publications
8
Citations
2.3K
H-Index
Active since
2020
Affiliations
University of Nottingham(Current)
University of Bristol
King's College London
University of Cambridge
University of Oxford
Tejas Ingle is an author at University of Nottingham specializing in pharmacotherapy, 28-day mortality, and primary outcome analysis.
Publications per year
2020–2024
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +6
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
COVID-19 and pneumothorax: a multicentre retrospective case series
Anthony W. Martinelli, Tejas Ingle, Joseph Newman et al. · European Respiratory Journal · 2020 · 345 citations · Full text
Medicine, Clinical Sciences, Infectious Diseases +6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
1–5 of 8